cyclosporine has been researched along with Hematologic Diseases in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (26.09) | 18.2507 |
| 2000's | 23 (50.00) | 29.6817 |
| 2010's | 8 (17.39) | 24.3611 |
| 2020's | 3 (6.52) | 2.80 |
| Authors | Studies |
|---|---|
| Escribano, A; Ferrer, C; Glaría, L; Huertas, C; Morera, R; Ocanto, A; Pérez, A; Rodríguez, I | 1 |
| Malpica, L; Moll, S | 1 |
| Atilla, H; Bingöl Kızıltunç, P; Büyüktepe, TÇ; Ertem, M; İleri, T; İnce, E; Yalçındağ, FN | 1 |
| D'Ascenzo, G; Feci, L; Fimiani, M; Marotta, G; Murdaca, F; Poggiali, S; Rubegni, P | 1 |
| Crepeau, RL; Duran-Struuck, R; Fishman, JA; Huang, CA; Matar, AJ; Pathiraja, V; Robson, S; Sachs, DH; Spitzer, TR | 1 |
| Caballero, D; Caballero-Velázquez, T; Castilla-Llorente, C; Encinas, C; Heras, I; López-Corral, L; Martino, R; Pérez-Simón, JA; Rosiñol, L; Sampol, A; San Miguel, J; Serrano, D | 1 |
| Bao, JA; Ding, XL; Miao, LY; Xue, L; Zhang, JJ; Zhang, WW | 1 |
| Balduzzi, A; Cesaro, S; Dini, G; Favre, C; Lanino, E; Locatelli, F; Messina, C; Pession, A; Pollichieni, S; Rabusin, M; Rondelli, R; Santarone, S | 1 |
| Barba, P; Briones, J; Brunet, S; Delgado, J; Martino, R; Piñana, JL; Querol, L; Sierra, J; Sureda, A; Valcárcel, D | 1 |
| Salgo, R; Thaçi, D | 1 |
| Epailly, E; Lorho, R | 1 |
| Barba, P; Brunet, S; Carreras, E; Fernández-Avilés, F; Martínez, C; Martino, R; Piñana, JL; Rovira, M; Sierra, J; Sureda, A; Valcárcel, D | 1 |
| Bruijnen, CP; Cornelisse, PB; Cornelissen, JJ; Emmelot, M; Huisman, C; Huls, G; Janssen, JJ; Kersten, MJ; Kneppers, E; Lokhorst, HM; Meijer, E; Minnema, MC; Mutis, T; Sonneveld, P; van der Holt, B; Zweegman, S | 1 |
| Airaghi, L; Annaloro, C; Cortelezzi, A; Deliliers, GL; Onida, F; Saporiti, G | 1 |
| Davies, SM; Jodele, S; Lawrence, J; Marsh, RA; Myers, KC | 1 |
| Anasetti, C; Blume, KG; Chauncey, T; Deininger, M; Hegenbart, U; Lange, T; Little, MT; Maloney, DG; Maris, M; McSweeney, PA; Niederwieser, D; Petersdorf, E; Pönisch, W; Sandmaier, BM; Shizuru, JA; Storb, RF; Storer, B; Woolfrey, A | 1 |
| Davidson, A; Dick, G; Pinkerton, R; Pritchard-Jones, K | 1 |
| Calevo, MG; Castagnola, E; Dallorso, S; Dini, G; Faraci, M; Fondelli, MP; Gaggero, R; Haupt, R; Lanino, E; Manzitti, C; Morreale, G | 1 |
| Ohyashiki, K; Shimamoto, T | 1 |
| Aymerich, M; Carreras, E; Fernández-Avilés, F; Jiménez, M; Martínez, C; Montserrat, E; Rovira, M; Talarn, C; Urbano-Ispizua, A | 1 |
| Hamaki, T; Hayashi, T; Kami, M; Kanemaru, M; Kim, SW; Kishi, Y; Kobayashi, K; Kusumi, E; Masuo, S; Miyakoshi, S; Mori, S; Morinaga, S; Murashige, N; Muto, Y; Takaue, Y; Taniguchi, S; Ueyama, J; Yuji, K | 1 |
| Hamaki, T; Hayashi, T; Ikeda, M; Kami, M; Kanemaru, M; Katayama, Y; Kato, D; Kim, SW; Kishi, Y; Kobayashi, K; Kusumi, E; Matsumura, T; Miyakoshi, S; Mori, S; Morinaga, S; Murashige, N; Takaue, Y; Taniguchi, S; Yuji, K | 1 |
| de Wit, M; Kröger, N; Krüger, WH; Renges, H; Rüssmann, B; Sobottka, I; Zander, AR | 1 |
| Doria, C; Doyle, HR; Fung, JJ; Gruttadauria, S; Jain, AK; Marino, IR; Scott, VL | 1 |
| Aisa, Y; Ikeda, Y; Mori, T; Nakazato, T; Okamoto, S; Shimizu, T; Yamazaki, R | 1 |
| Ahmed, P; Altaf, C; Anwar, M; Hashmi, K; Hussain, I; Iqbal, H; Kamal, K; Khan, B; Khan, MA; Malik, HS; Naeem, M; Raza, S | 1 |
| Alderden-Los, C; Beijnen, JH; Rosing, H; Schellens, JH; Sharma, A; Veltkamp, SA | 1 |
| Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K | 1 |
| Kami, M; Kato, D; Kishi, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Narimatsu, H; Takagi, S; Taniguchi, S; Tanimoto, T; Uchida, N; Wake, A; Yamaguchi, T; Yuji, K | 1 |
| Al-Hazzouri, A; Burns, LJ; Cao, Q; Majhail, NS; Weisdorf, DJ | 1 |
| Blume, KG; Chao, N; Forman, SJ; Kashyap, A; Long, GD; Margolin, K; Molina, A; Nademanee, A; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Planas, I; Schmidt, GM; Smith, EP; Snyder, DS; Somlo, G; Spielberger, R; Stein, AS; Stepan, DE; Wilsman, K; Zwingenberger, K | 1 |
| Habertheuer, KH; Hinterberger-Fischer, M; Kalhs, P; Kier, P; Lechner, K; Ruckser, R; Schmid, A; Sebesta, C; Spona, J; Tiefengraber, E | 1 |
| Buser, U; Gengenbacher, D; Gimmi, C; Gratwohl, A; Haberthür, C; Passweg, J; Pless, M; Signer, E; Stauffer, G; Tichelli, A | 1 |
| Gratwohl, A; Loeffler, BM; Luescher, TF; Marbet, GA; Speck, B; Tsakiris, DA | 1 |
| Baraldo, M; Cossettini, P; Furlanut, M; Pea, F; Wu, G | 1 |
| Furlanut, M; Wu, G | 2 |
| Bertesi, M; Emilia, G; Ferrara, L; Gandini, G; Longo, G; Valenti, C | 1 |
| Cossettini, P; Furlanut, M; Pea, F; Wu, G | 1 |
| Jonásová, A; Neuwirtová, R | 1 |
| Bielack, S; de Wit, M; Dürken, M; Erttmann, R; Jaburg, N; Kabisch, H; Kröger, N; Krüger, W; Löliger, C; Renges, H; Rüssmann, B; Stockschläder, M; Wacker-Backhaus, G; Zabelina, T; Zander, AR | 1 |
| Ando, A; Bamba, T; Fujiyama, Y; Hodohara, K; Hoshino, N; Ikuno, Y; Inoue, T; Minouchi, T; Ohta, S; Shibata, N; Taga, T; Tsubakimoto, Y; Yamaji, A; Yoshio, K | 1 |
| Chong, G; Clot, J; Djamali, A; Leverson, G; Mourad, G; Portales, P; Turc-Baron, C | 1 |
| Beijnen, JH; Duchin, K; Koopman, FJ; Lieverst, J; Malingré, MM; Rosing, H; Schellens, JH; Swart, M; ten Bokkel Huinink, WW; van Tellingen, O | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Flowers, ME; Koc, S; Leisenring, W; Martin, PJ; Nash, RA; Sanders, JE; Storb, R; Witherspoon, RP | 1 |
| Anasetti, C; Appelbaum, FR; Bowden, RA; Deeg, HJ; Doney, K; Longton, G; Nash, RA; Pepe, MS; Pettinger, M; Storb, R | 1 |
4 review(s) available for cyclosporine and Hematologic Diseases
| Article | Year |
|---|---|
Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases.
Topics: Adrenal Cortex Hormones; Aged; Antimetabolites; Cyclophosphamide; Cyclosporine; Female; Hematologic Diseases; Herpes Zoster; Humans; Immunosuppressive Agents; Infection Control; Infections; Pneumonia, Pneumocystis; Strongyloidiasis | 2020 |
Treatment of moderate-to-severe plaque psoriasis.
Topics: Abnormalities, Drug-Induced; Alefacept; Antibodies, Monoclonal; Clinical Trials as Topic; Contraindications; Cyclosporine; Etanercept; Female; Fumarates; Hematologic Diseases; Humans; Hypertension; Immunoglobulin G; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Photochemotherapy; Pregnancy; Pregnancy Complications; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retinoids; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2009 |
Metabolic syndrome in patients with hematological diseases.
Topics: Adrenal Cortex Hormones; Cyclosporine; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Insulin Resistance; Metabolic Syndrome; Risk Factors | 2012 |
[Use of cyclosporin A in hematology].
Topics: Cyclosporine; Hematologic Diseases; Humans; Immunosuppressive Agents | 1998 |
10 trial(s) available for cyclosporine and Hematologic Diseases
| Article | Year |
|---|---|
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Remission Induction; Reoperation; Salvage Therapy; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine | 2013 |
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Topics: Adolescent; Child; Child, Preschool; Communicable Diseases; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Postoperative Complications; Prospective Studies; Recurrence; Transplantation, Homologous | 2009 |
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Eruptions; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Lymphocyte Count; Male; Melphalan; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Prospective Studies; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 2011 |
Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Calcineurin Inhibitors; Creatinine; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnesium; Male; Middle Aged; Tacrolimus; Transplantation, Homologous | 2005 |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
Topics: Acute Disease; Adult; Aged; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Tacrolimus | 2007 |
Thalidomide as salvage therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chronic Disease; Constipation; Cyclosporine; Drug Eruptions; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Neuritis; Neutropenia; Prednisone; Remission Induction; Salvage Therapy; Survival Rate; Thalidomide; Treatment Outcome | 1995 |
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Topics: Adolescent; Adult; Anti-Infective Agents; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Histocompatibility Testing; Humans; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Infant; Male; Methotrexate; Metronidazole; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1999 |
Adsorption and pharmacokinetics of cyclosporin A in relation to mode of infusion in bone marrow transplant patients.
Topics: Adsorption; Adult; Biocompatible Materials; Bone Marrow Transplantation; Butadienes; Cyclosporine; Elastomers; Equipment Design; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Polyethylene; Polymers; Polyvinyl Chloride | 2000 |
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Small Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Stomach Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Survival Analysis; Thrombocytopenia; Transplantation, Homologous | 2002 |
32 other study(ies) available for cyclosporine and Hematologic Diseases
| Article | Year |
|---|---|
TLI in pediatric patients.
Topics: Adolescent; Antibiotic Prophylaxis; Child; Child, Preschool; Cyclosporine; Dose Fractionation, Radiation; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Irradiation; Male; Myeloablative Agonists; Transplantation Conditioning; Transplantation, Haploidentical; Treatment Outcome | 2020 |
Ocular Findings of Pediatric Dry Eye Related to Graft-Versus-Host Disease
Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Conjunctiva; Cyclosporine; Dry Eye Syndromes; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Retrospective Studies; Tears; Transplantation, Homologous | 2021 |
Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Topics: Acute Disease; Adult; Allografts; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Photopheresis; Retrospective Studies; Stem Cell Transplantation; Steroids; Transplantation Conditioning | 2013 |
Effects of mobilization regimens in donors on outcomes of hematopoietic cell transplantation in miniature Swine.
Topics: Animals; Cyclosporine; Cytokines; DNA Primers; Graft Survival; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Immunotoxins; Leukapheresis; Polymerase Chain Reaction; Swine; Swine, Miniature; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2012 |
Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
Topics: Adult; Anemia, Aplastic; ATP Binding Cassette Transporter, Subfamily B; Cohort Studies; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Models, Biological; Myelodysplastic Syndromes; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2014 |
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Cerebral Hemorrhage; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Meningoencephalitis; Middle Aged; Myeloablative Agonists; Nervous System Diseases; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Postoperative Complications; Recurrence; Retrospective Studies; Risk Factors; Stroke; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2009 |
[Side effects of proliferation signal inhibitors and their management].
Topics: Angioedema; Calcineurin Inhibitors; Cicatrix; Cyclosporine; Graft Rejection; Graft Survival; Hematologic Diseases; Humans; Hyperlipidemias; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Kidney Diseases; Lymphocele; Pneumonia; Protein Serine-Threonine Kinases; Sirolimus; Skin Diseases; TOR Serine-Threonine Kinases | 2009 |
MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Fibrinolytic Agents; Glucocorticoids; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infant; Liver; Male; Methylprednisolone; Myeloablative Agonists; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2013 |
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce dura
Topics: Adult; Aged; Child; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Remission Induction; Survival Rate; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2003 |
EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)-chemotherapy selected for multidrug resistance modulation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Kidney Diseases; Male; Neoplasms; Vincristine | 2002 |
Severe neurologic complications after hematopoietic stem cell transplantation in children.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Electroencephalography; Female; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Metabolism, Inborn Errors; Nervous System Diseases; Neurologic Examination; Neurotoxicity Syndromes; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplantation, Homologous; Whole-Body Irradiation | 2002 |
Myelodysplastic syndrome with erythroid hypoplasia is a new clinical entity responsive to cyclosporin A therapy.
Topics: Bone Marrow Cells; Cyclosporine; Erythrocytes; Gene Rearrangement; Hematologic Diseases; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Stem Cells; T-Lymphocytes; Time Factors | 2002 |
Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.
Topics: Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Middle Aged; Myeloid Cells; Prospective Studies; T-Lymphocytes; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2003 |
Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
Topics: Adult; Aged; Blood Platelets; Cyclosporine; Feasibility Studies; Female; Fetal Blood; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neutrophils; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2004 |
Early central nervous system complications after reduced-intensity stem cell transplantation.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Brain Diseases, Metabolic; Central Nervous System Diseases; Cerebrovascular Disorders; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Limbic Encephalitis; Male; Middle Aged; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 2004 |
Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infant; Liposomes; Male; Middle Aged; Mycoses; Opportunistic Infections | 2005 |
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Gastrointestinal Diseases; Graft Rejection; Hematologic Diseases; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Nervous System Diseases; Retreatment; Retrospective Studies; Tacrolimus; Treatment Outcome | 2003 |
Graft versus host disease in allogeneic stem cell transplantation--3 1/2 years experience.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Middle Aged; Pakistan; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2005 |
A pharmacokinetic and safety study of a novel polymeric paclitaxel formulation for oral application.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Area Under Curve; Capsules; Central Nervous System Diseases; Chemistry, Pharmaceutical; Cyclosporine; Female; Gastrointestinal Diseases; Half-Life; Hematologic Diseases; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Neoplasms; Paclitaxel; Polymers | 2007 |
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug Induced Liver Injury; Cholangitis; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Diseases; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Incidence; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Melphalan; Middle Aged; Postoperative Complications; Risk Factors; Tacrolimus; Tissue Donors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Topics: Adult; Age Factors; Aged; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Proportional Hazards Models; Risk; Survivors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Longitudinal Studies; Male; Middle Aged; Prolactin; Radioimmunoassay; Sex Characteristics; Transplantation, Autologous; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
[How long should cyclosporin be administered following bone marrow transplantation?].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Creatinine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Middle Aged; Retrospective Studies; Whole-Body Irradiation | 1994 |
Endothelin in the early phase of bone marrow transplantation.
Topics: Blood Pressure; Blood Proteins; Bone Marrow Transplantation; Creatinine; Cyclosporine; Endothelins; Graft Rejection; Hematologic Diseases; Humans; Radioimmunoassay | 1994 |
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods.
Topics: Adult; Aged; Bayes Theorem; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Least-Squares Analysis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by means of total, lean and different adipose factors dosing body weight using Bayesian and non-linear least squares methods.
Topics: Adult; Bayes Theorem; Bias; Body Weight; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Immunosuppressive Agents; Least-Squares Analysis; Linear Models; Male; Middle Aged; Sex Factors; Software | 1996 |
Clinical interaction between grapefruit juice and cyclosporine: is there any interest for the hematologists?
Topics: Administration, Oral; Adult; Aged; Autoimmune Diseases; Beverages; Biological Availability; Citrus; Cyclosporine; Drug Synergism; Evaluation Studies as Topic; Female; Flavonoids; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome | 1998 |
Effect of the number of samples on Bayesian and non-linear least-squares individualization: a study of cyclosporin treatment of haematological patients with multidrug resistance.
Topics: Adult; Bayes Theorem; Cyclosporine; Drug Resistance, Multiple; Fluorescence Polarization Immunoassay; Hematologic Diseases; Humans; Immunosuppressive Agents; Least-Squares Analysis; Predictive Value of Tests; Sample Size; Software | 1998 |
Prediction of blood cyclosporine concentrations in non-obese and obese hematologic patients with multidrug resistance using total, lean and different adipose factor dosing body weights.
Topics: Adult; Body Weight; Cyclosporine; Drug Resistance, Multiple; Female; Hematologic Diseases; Humans; Male; Middle Aged; Obesity | 1999 |
Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring.
Topics: Adult; Aged; Animals; Antilymphocyte Serum; Blood Cells; Clonal Deletion; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Rejection; Health Care Costs; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Kidney; Kidney Transplantation; Lymphocytes; Male; Middle Aged; Rabbits | 2000 |
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Leukemia; Lymphoma; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors; Sex Factors; Survival Analysis; Tissue Donors; Transplantation, Homologous; Whole-Body Irradiation | 1992 |